Scancell Holdings Plc – Board Appointment

Scancell Holdings Plc – Board Appointment

Scancell, the developer of novel immunotherapies for the treatment of cancer, announces that, further to the Company’s announcement on 13 June 2019, Martin Diggle, Co-Founder and Portfolio Manager of Vulpes Investment Management, has been appointed to the Company’s Board of Directors as a Non-Executive Director with immediate effect.  

Mr Diggle has over 30 years’ experience in investment banking and fund management and has been an investor in life sciences and biotechnology companies for nearly 20 years. He is also an expert in Emerging Markets and Russia, where he was previously a partner and director of UBS Brunswick. He holds a Master’s Degree in Philosophy, Politics and Economics from University of Oxford. 

No Comments

Post a Comment